Replimune Group Inc (REPL)
6.15
-0.18
(-2.84%)
USD |
NASDAQ |
Apr 25, 16:00
6.16
+0.01
(+0.16%)
After-Hours: 20:00
Replimune Group Market Cap: 377.54M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 377.54M |
| April 24, 2024 | 388.58M |
| April 23, 2024 | 394.11M |
| April 22, 2024 | 394.11M |
| April 19, 2024 | 395.95M |
| April 18, 2024 | 427.87M |
| April 17, 2024 | 442.61M |
| April 16, 2024 | 438.92M |
| April 15, 2024 | 437.08M |
| April 12, 2024 | 438.31M |
| April 11, 2024 | 441.38M |
| April 10, 2024 | 427.26M |
| April 09, 2024 | 446.90M |
| April 08, 2024 | 437.08M |
| April 05, 2024 | 451.81M |
| April 04, 2024 | 450.59M |
| April 03, 2024 | 433.40M |
| April 02, 2024 | 437.70M |
| April 01, 2024 | 474.53M |
| March 28, 2024 | 501.54M |
| March 27, 2024 | 506.45M |
| March 26, 2024 | 472.07M |
| March 25, 2024 | 494.17M |
| March 22, 2024 | 503.38M |
| March 21, 2024 | 503.38M |
| Date | Value |
|---|---|
| March 20, 2024 | 497.86M |
| March 19, 2024 | 507.06M |
| March 18, 2024 | 508.29M |
| March 15, 2024 | 523.64M |
| March 14, 2024 | 542.67M |
| March 13, 2024 | 551.26M |
| March 12, 2024 | 534.07M |
| March 11, 2024 | 543.28M |
| March 08, 2024 | 554.33M |
| March 07, 2024 | 542.67M |
| March 06, 2024 | 553.10M |
| March 05, 2024 | 528.55M |
| March 04, 2024 | 545.12M |
| March 01, 2024 | 550.65M |
| February 29, 2024 | 526.71M |
| February 28, 2024 | 534.69M |
| February 27, 2024 | 543.90M |
| February 26, 2024 | 528.55M |
| February 23, 2024 | 505.22M |
| February 22, 2024 | 488.03M |
| February 21, 2024 | 469.00M |
| February 20, 2024 | 469.62M |
| February 16, 2024 | 474.53M |
| February 15, 2024 | 470.23M |
| February 14, 2024 | 421.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
316.98M
Minimum
Sep 03 2019
2.420B
Maximum
Dec 01 2020
1.003B
Average
935.73M
Median
Apr 05 2023
Market Cap Benchmarks
| Esperion Therapeutics Inc | 368.25M |
| SI-BONE Inc | 585.99M |
| Gossamer Bio Inc | 151.14M |
| Olema Pharmaceuticals inc | 549.64M |
| NovaBay Pharmaceuticals Inc | 2.318M |
Market Cap Related Metrics
| Price to Book Value | 0.8956 |
| Price | 6.15 |
| Earnings Yield | -51.38% |